News

US FDA declines to approve Regeneron's blood cancer therapy for second time
Regeneron said on Friday the U.S. Food and Drug Administration has once again declined to approve its blood cancer therapy, ...
WSLS 10 News3h
FDA to require opioid pain medication labeling to emphasize risks
The U.S. Food and Drug Administration is taking significant steps in the ongoing fight against the Opioid Crisis.
FDA Vaccine Chief Steps Down After Controversial Tenure
During his first term, Trump signed the “Right to Try” law, which allows terminally ill patients to seek treatments that ...
Controversial FDA official Dr. Vinay Prasad departs agency
Dr. Vinay Prasad, the controversial critic of the US Food and Drug Administration who took a top role at the regulatory ...
Fierce Healthcare3h
FDA requires label changes to all opioid pain meds to clarify risks
The FDA is requiring safety labeling changes to all opioid painkillers, to better highlight the risks posed by using the ...
FDA Issues Risk Warning Over Nationwide Butter Recall
Bunge North America Inc. initiated a voluntary recall of 64,800 pounds of butter due to a potential undeclared allergen.
FDA Recalls Freeze Dried Fruit Due to Potential Listeria Contamination
Member’s Mark Freeze Dried Fruit sold at Sam’s Club was recalled by the FDA over potential listeria contamination. Here’s a ...
Fierce Pharma4h
Lenz's Vizz wins FDA approval to crack 'large, untapped' market for presbyopia
Lenz Therapeutics has earned the FDA’s go-ahead for its aceclidine eye drop to crack the large presbyopia market, where past ...
PharmExec2h
FDA Approves Label Update for Novartis’ Leqvio to Enable Twice-Yearly Monotherapy for LDL-C Management in Adults with Hypercholesterolemia
The updated label no longer requires Leqvio (inclisiran) to be used in combination with statins for low-density lipoprotein ...